181 related articles for article (PubMed ID: 12395996)
1. Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux.
Habermann W; Kiesler K; Eherer A; Friedrich G
J Voice; 2002 Sep; 16(3):425-32. PubMed ID: 12395996
[TBL] [Abstract][Full Text] [Related]
2. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
Fitton A; Wiseman L
Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
[TBL] [Abstract][Full Text] [Related]
3. Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy.
Habermann W; Eherer A; Lindbichler F; Raith J; Friedrich G
J Laryngol Otol; 1999 Aug; 113(8):734-9. PubMed ID: 10748849
[TBL] [Abstract][Full Text] [Related]
4. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.
Eherer AJ; Habermann W; Hammer HF; Kiesler K; Friedrich G; Krejs GJ
Scand J Gastroenterol; 2003 May; 38(5):462-7. PubMed ID: 12795454
[TBL] [Abstract][Full Text] [Related]
5. Pantoprazole.
Poole P
Am J Health Syst Pharm; 2001 Jun; 58(11):999-1008. PubMed ID: 11402494
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
7. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
Cheer SM; Prakash A; Faulds D; Lamb HM
Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole: a new proton pump inhibitor.
Jungnickel PW
Clin Ther; 2000 Nov; 22(11):1268-93. PubMed ID: 11117653
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
10. Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.
Thomson AB
Curr Gastroenterol Rep; 2000 Dec; 2(6):482-93. PubMed ID: 11079051
[TBL] [Abstract][Full Text] [Related]
11. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
Miner P; Katz PO; Chen Y; Sostek M
Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
[TBL] [Abstract][Full Text] [Related]
12. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with pantoprazole in gastroesophageal reflux disease.
Avner DL
Clin Ther; 2000 Oct; 22(10):1169-85; discussion 1149-50. PubMed ID: 11110229
[TBL] [Abstract][Full Text] [Related]
14. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.
Netzer P; Gut A; Brundler R; Gaia C; Halter F; Inauen W
Aliment Pharmacol Ther; 2001 Sep; 15(9):1375-84. PubMed ID: 11552908
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of controloc in the treatment of acid-dependent diseases].
Chubenko SS; Gaĭdukov VO; Agibalov AN; Onishenko AV
Lik Sprava; 2003 Dec; (8):103-4. PubMed ID: 14965022
[TBL] [Abstract][Full Text] [Related]
16. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
17. An overview of proton pump inhibitors.
Der G
Gastroenterol Nurs; 2003; 26(5):182-90. PubMed ID: 14603076
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.
Madan K; Ahuja V; Kashyap PC; Sharma MP
Dis Esophagus; 2004; 17(4):274-8. PubMed ID: 15569362
[TBL] [Abstract][Full Text] [Related]
19. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
20. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
Mössner J; Koop H; Porst H; Wübbolding H; Schneider A; Maier C
Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
